AVDL - Avadel Pharmaceutica...

Valuation of Avadel Pharmaceuticals plc(AVDL), Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead pr

Avadel Pharmaceuticals plc

AVDL

NASDAQ

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

17.33 USD

-0.05 (-0.289%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Apr 19, 2024 4:00 PM

Share Price on Valuation Date

$17.33

Stock Beta

1.632

Shares Outstanding

90577000

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.